panobacumab

{{short description|Monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa}}

{{Drugbox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 458269582

| image =

| type = mab

| mab_type = mab

| source = u

| target = Pseudomonas aeruginosa serotype IATS O11

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|changed|??}}

| CAS_number = 885053-97-4

| ATC_prefix = none

| ATC_suffix =

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 62B4OXU259

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = none

| C=38714 | H=60189 | N=10637 | O=12187 | S=322

}}

Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa.[https://www.who.int/entity/medicines/publications/druginformation/innlists/PL100prepubli.pdf International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy)], World Health Organization.

It is a fully human pentameric IgM antibody with a mouse J chain.

Image:IgM.pngs.
3: Light chains.
4: J chain.
5: Intermolecular disulfide bonds.]]